RSS Feeds
Adriamycin Cardiotoxicity
- ROBERT A. MINOW, M.D.; and
- JEFFREY A. GOTTLIEB, M.D.
- LEON FRAZIN, M.D.; and
- EFRAIN GARCIA, M.D.
Excerpt
To the editor: Rinehart, Lewis, and Balcerzak (1) recommend the use of systolic time intervals for the early detection of adriamycin cardiotoxicity. As they suggest, the early detection of significant cardiotoxicity would allow a more accurate decision on the dose limitation of adriamycin. Their Figure 1A suggests a continuous increase in systolic time intervals with increasing adriamycin dose, yet they only give the data on two patients. It would be more interesting to see if a dose response curve could be formed from all their cases.
In eight of their nine (89%) patients who received > 300 mg/m2 body surface
